Stem cell therapy helped to reduce the number of heart attacks, strokes and death among people with chronic, high-risk, NYHA class II or III heart failure with reduced ejection fraction (HFrEF), especially among those who ...
Nov 15, 2021
0
69
Canagliflozin, a medication used to treat type 2 diabetes, was found to greatly improve symptoms and quality of life within 3 months for people with heart failure due to either reduced or preserved cardiac function, even ...
Nov 15, 2021
0
4
Cardiac rehabilitation enrollment rose among adults with heart failure with reduced ejection fraction after Medicare started covering it in 2014, yet overall enrollment among Medicare beneficiaries remains very low—less ...
Nov 8, 2021
0
3
A special artificial intelligence (AI)-based computer algorithm created by Mount Sinai researchers was able to learn how to identify subtle changes in electrocardiograms (also known as ECGs or EKGs) to predict whether a patient ...
Oct 19, 2021
0
101
A year of exercise training helped to preserve or increase the youthful elasticity of the heart muscle among people showing early signs of heart failure, a small study shows.
Sep 21, 2021
1
216
Clinical cardiac complications were "reassuringly" uncommon among more than 600 patients admitted to hospital with COVID-19 in 2020, according to research published today by the Medical Journal of Australia.
Sep 6, 2021
0
10
Finerenone reduces the risk of cardiovascular morbidity and mortality in patients with mild-to-moderate kidney disease and type 2 diabetes. That's the finding of late breaking research presented in a Hot Line session today ...
Aug 30, 2021
0
4
Empagliflozin reduces the risk of a composite of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction (HFpEF) with or without diabetes. That's the finding ...
Aug 27, 2021
0
176
Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of serious arrhythmias in high-risk post-infarction patients with cardiac autonomic dysfunction and moderately reduced ejection ...
Aug 27, 2021
0
37
A pooled analysis of two randomized trials has demonstrated the beneficial effects of empagliflozin in patients with heart failure with a reduced and preserved ejection fraction. The late breaking study is presented in a ...
Aug 27, 2021
0
2
